Monday, Dec 18, 2017
engineered enzymes for better healthcare

An Irish company was due to launch a novel newborn screening test for phenylketonuria (PKU) at a major international meeting in Prague this week. Enzolve Technologies was due to formally launch its diagnostic test at the 6th International Society for Neonatal Screening European Regional Meeting, which took place in Prague from April 26-28...

Read full article on the web     Irish Medical Times Apr 29, 2009     or in pdf format   pdf_button

 

  Back to the News page 

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...